CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $34,349
- in 1 filing
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-05-16 | Ayer Capital Management, LP 10% owner | Sale | −140,300 | $0.67 | $94K | 2,617,320 |
| 2012-05-15 | Ayer Capital Management, LP 10% owner | Sale | −1,000 | $0.85 | $850 | 2,757,620 |
| 2012-03-22 | THOMPSON STEPHEN B CFO | Other disposition · Stock option (right to buy) | −6,000 | $18.65 | $112K | 437,000 |
| 2012-03-22 | NOWOTNIK DAVID P Sr. VP R&D | Other disposition · Stock option (right to buy) | −10,000 | $18.65 | $187K | 545,000 |
| 2012-01-23 | Howell Stephen B. Director | Grant or award | +300 | 495 | ||
| 2012-01-23 | THOMPSON STEPHEN B CFO | Grant or award | +15,000 | $1.36 | $20K | 18,521 |
| 2012-01-23 | NOWOTNIK DAVID P Sr. VP R&D | Grant or award | +15,000 | $1.36 | $20K | 20,116 |
| 2011-05-26 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +700 | 700 | ||
| 2011-05-26 | NOWOTNIK DAVID P Sr. VP R&D | Grant or award · Stock option (right to buy) | +12,500 | $2.27 | $28K | 467,500 |
| 2011-05-26 | NOWOTNIK DAVID P Sr. VP R&D | Grant or award · Stock option (right to buy) | +37,500 | $2.27 | $85K | 505,000 |
| 2011-05-26 | THOMPSON STEPHEN B CFO | Grant or award · Stock option (right to buy) | +12,500 | $2.27 | $28K | 355,500 |
| 2011-05-26 | THOMPSON STEPHEN B CFO | Grant or award · Stock option (right to buy) | +37,500 | $2.27 | $85K | 393,000 |
| 2010-05-26 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +600 | 600 | ||
| 2010-05-26 | THOMPSON STEPHEN B CFO | Grant or award · Stock option (right to buy) | +100,000 | $2.45 | $245K | 343,000 |
| 2010-02-01 | NOWOTNIK DAVID P Sr VP R&D | Grant or award · Stock option (right to buy) | +200,000 | $2.79 | $558K | 455,000 |
| 2009-06-01 | LUCI DAVID P Director | Grant or award | +200,000 | 263,217 | ||
| 2009-05-27 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +500 | 500 | ||
| 2009-05-27 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +200 | 200 | ||
| 2009-05-27 | LUCI DAVID P Director | Grant or award · Stock option (right to buy) | +25,000 | $1.38 | $35K | 68,500 |
| 2009-05-27 | LUCI DAVID P Director | Grant or award · Stock option (right to buy) | +20,000 | $1.38 | $28K | 88,500 |
Page 26 of 34 · 664 trades